Anne Layne-Farrar provided economic analyses to support Finjan’s claim of infringement of eight antivirus product patents in a lawsuit against Sophos. We assisted in determining damages. The jury found Sophos had infringed all eight patents and awarded Finjan $15 million in damages, the maximum amount presented by CRA. Our work was led by Anne Layne-Farrar and included Mensur Muhamedagic, Saumit Sahi, and Tuba Sahiti.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...